Oncology & Cancer

Scientists find a new way to boost common cancer drugs

Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue ...

Oncology & Cancer

PR+ cells add prognostic value in luminal A breast cancer

(HealthDay)—Semiquantitative immunohistochemical expression of progesterone receptor-positive tumor cells improves prediction of survival within luminal A breast cancers, according to a study published online Dec. 10 in ...

Oncology & Cancer

Vandetanib doesn't up survival in non-small-cell lung cancer

(HealthDay) -- Vandetanib does not improve overall survival for patients who have received previous treatment for advanced non-small-cell lung cancer (NSCLC), according to a study published online Feb. 27 in the Journal of ...

Oncology & Cancer

The link between TB and a gene mutation that causes lung cancer

Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease ...

page 9 from 15